EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia

Accumulating studies have proved EZH2 dysregulation mediated by mutation and expression in diverse human cancers including AML. However, the expression pattern of EZH2 remains controversial in acute myeloid leukaemia (AML). EZH1/2 expression and mutation were analysed in 200 patients with AML. EZH2...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Cell Mol Med
Главные авторы: Chu, Ming‐qiang, Zhang, Ting‐juan, Xu, Zi‐jun, Gu, Yu, Ma, Ji‐chun, Zhang, Wei, Wen, Xiang‐mei, Lin, Jiang, Qian, Jun, Zhou, Jing‐dong
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2019
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6991666/
https://ncbi.nlm.nih.gov/pubmed/31794134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14855
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы